Article

Enhancing Breast Cancer Therapy: Nanocarrier-Based Targeted Drug Delivery

2023-12-09

Abstract excerpt

Breast cancer (BC) is one of the most common types of cancer in women. Triple-negative breast cancer (TNBC), characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), exhibits a highly aggressive phenotype with increased metastasis and resistance to conventional treatments. Nanocarrier technology is consistently employed to overcome lim...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a442957f-f711-5651-b828-a4f3e6660163
DOI: 10.20944/preprints202312.0632.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Enhancing Breast Cancer Therapy: Nanocarrier-Based Targeted Drug DeliveryDOI 10.20944/preprints202312.0632.v1Read

Amino Acid Polymer-Based Nano-Carriers for Targeted Drug Delivery in Breast Cancer Therapy: Mechanisms, Applications, and Future PerspectivesSemantic proximity Read

Ligand conjugated lipid-based nanocarriers for cancer theranosticsSemantic proximity Read

Triple Negative Breast Cancer Treatment Options and Limitations: Future OutlookSemantic proximity Read

Enhancing Cancer Therapy through Polymeric Nano-particles: Targeted Drug Delivery StrategiesSemantic proximity Read

Nanomedicine Strategies to Overcome Multi-Drug Resistance in Cancer: Innovations in Targeted Delivery, Tumor Microenvironment Modulation and Synergistic TherapiesSemantic proximity Read

DNA Nanoflower Enables Controlled Co-Delivery of Antisense Oligodeoxynucleotide and Doxorubicin for Anti-breast Cancer TreatmentSemantic proximity Read

Nanoparticle-based drug delivery systems: What can they really do in vivo?Semantic proximity Read

Red Blood Cell-derived Extracellular Vesicles enable Cisplatin and Cetuximab combined Therapy against Triple-Negative Breast CancerSemantic proximity Read

Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel ApproachSemantic proximity Read

Targeted Delivery of siRNA through Nanocomplex using Specific Fusion Peptides for Breast Cancer TreatmentSemantic proximity Read

Ultrasound-Activated Nanobubbles Induce Durable Systemic Antitumor ImmunitySemantic proximity Read

Gene expression profiles of some prognostic markers in a human breast cell line (MCF7) exposed to Curcumin nanoparticles and nanocapsulesSemantic proximity Read